These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis--a pilot study. Omdal R; Gunnarsson R Rheumatol Int; 2005 Aug; 25(6):481-4. PubMed ID: 15071755 [TBL] [Abstract][Full Text] [Related]
30. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Bresnihan B; Cobby M Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii22-8. PubMed ID: 12817092 [TBL] [Abstract][Full Text] [Related]
31. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis]. Zündorf I; Dingermann T Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457 [No Abstract] [Full Text] [Related]
32. Anakinra (interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis. Kavanaugh A Adv Ther; 2006; 23(2):208-17. PubMed ID: 16751154 [TBL] [Abstract][Full Text] [Related]
33. Beneficial response to interleukin 1 receptor antagonist in traps. Simon A; Bodar EJ; van der Hilst JC; van der Meer JW; Fiselier TJ; Cuppen MP; Drenth JP Am J Med; 2004 Aug; 117(3):208-10. PubMed ID: 15300976 [No Abstract] [Full Text] [Related]
34. Anakinra for arthritis. Pestell K Trends Pharmacol Sci; 2001 Aug; 22(8):401. PubMed ID: 11478998 [No Abstract] [Full Text] [Related]
35. Anakinra treatment of patients with rheumatoid arthritis. Calabrese LH Ann Pharmacother; 2002; 36(7-8):1204-9. PubMed ID: 12086555 [TBL] [Abstract][Full Text] [Related]
36. Using anakinra for adult rheumatoid arthritis. Kastanek L Nurse Pract; 2002 Apr; 27(4):62-5. PubMed ID: 11984420 [No Abstract] [Full Text] [Related]
37. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv2-14. PubMed ID: 16239380 [No Abstract] [Full Text] [Related]
38. Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Lovell DJ; Bowyer SL; Solinger AM Arthritis Rheum; 2005 Apr; 52(4):1283-6. PubMed ID: 15818707 [TBL] [Abstract][Full Text] [Related]
39. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Rynne M; Maclean C; Bybee A; McDermott MF; Emery P Ann Rheum Dis; 2006 Apr; 65(4):533-4. PubMed ID: 16531551 [TBL] [Abstract][Full Text] [Related]
40. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis. Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]